Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Tanguay

<< Previous

Bullboard Posts

Next >>

Comment by Bucknelly21on Jan 14, 2021 1:07pm

133 Views

Post# 32297730

RE:RE:RE:RE:Tanguay

Single most disappointing thing of all of this is that Thtx was unable to take advantage of a massive bull market. Every company and their mom has massive inflated evaluations and Thtx just got left in the dust. No one would have been upset my this deal nearly as much if they had

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China